Transaction completed in Q4 FY23
- ~€11m investment in 2019, originated and managed by ICG
- Realisation in the final quarter of the financial year to 31 January 2023 (FY23)
- Sale generated proceeds of £24.3m in FY23
Differentiated business model
Consolidated network of suppliers, mainly in Europe and China, to maintain an asset light business model.
Structural growth drivers
Growing health & wellness market increasing health awareness among consumers, underpinned by structural demographic drivers from an aging population.
Dominant market position
Leading manufacturer in a concentrated and heavily regulated market with high barriers to entry.
Management team with over 20 years sector experience and a successful previous buy-out track record.